Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος της αδιπονεκτίνης στη μη αλκοολική λιπώδη νόσο του ήπατος
Abstract
dc:descriptionBackground & Aims: Adiponectin, an adipocytokine mediating insulin action, has recently been involved in the pathogenesis of non-alcoholic steatohepatitis (NASH). Aim of this study was to examine possible associations of adiponectin with factors of the metabolic syndrome and with histological parameters in biopsy-proven non-alcoholic fatty liver disease (NAFLD). Methods: Patients with persistent abnormal liver function tests, after exclusion of other causes of chronic liver disease, were subjected to liver biopsy, in order to confirm diagnosis and stage NAFLD. Fibrosis stage and the NAFLD Activity Score (NAS) were recorded in each patient. Somatometrics including body mass index (BMI) and waist to hip ratio (WHR), factors of the metabolic syndrome (central obesity, hyperglycemia, hypertriglyceridemia, low HDL-cholesterol and hypertension), and biochemical tests were also recorded. Insulin resistance was calculated with HOMA and QUICKI index. Serum adiponectin concentration was measured by an enzyme-linked immunosorbent assay. Results: Forty-two NAFLD patients including 9 with NASH-related compensated cirrhosis were included in the study. Patient baseline characteristics were: 25 (59,5%) female, 32 (76,2%) ≥45 years old, mean BMI 30,82+5,54 kg/m², 19 (45,2%) insulin resistant and 6 (16,2%) with WHR>1. Presence of each factor of the metabolic syndrome was associated with hypoadiponectinemia. Adiponectin negatively correlated with HOMA (Pearson’s correlation coefficient r=-0,544, p=0,01). Adiponectin concentration was negatively associated with higher stages of fibrosis (one-way ANOVA, p=0,007). To further investigate the relationship between adiponectin and fibrosis stage we used the Spearman’s rank correlation method (rs=-0,551 p=0,00048). This negative correlation was independent of sex, age, BMI and HOMA. Adiponectin was found not to be associated with NAS (one-way ANOVA, p=0,392), steatosis grade (p=0,271), inflammation (p=0,104) and ballooning (p=0,251). Using the multivariate logistic regression, adiponectin, AST/ALT ratio and presence of WHR>1 were independent predictors of advanced fibrosis (stages F3 and F4). The receiver operating characteristic (ROC) curve for detecting advanced fibrosis using the combination of the three independent variables had an area under the curve of 0,902+0,054, p<0,0001. Conclusions: The results of this cross-sectional study suggest that taking into account clinical (WHR) and laboratory data (aminotransferase and adiponectin levels) could be useful in detecting advanced fibrosis, avoiding liver biopsy in most patients with NAFLD.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Savvidou, Savvoula
- Σαββίδου, Σαββούλα
Subjects
dc:subject × 14- Αδιπονεκτίνη
- Ήπαρ, Μη αλκοολική λιπώδης νόσος του
- Στεατοηπατίτιδα, Μη αλκοολική
- Μεταβολικό σύνδρομο
- Ινσουλίνη, Αντίσταση στην
- Adiponectin
- Liver diseases, Non alcoholic fatty
- Steatohepatitis, Non alcoholic
- Metabolic syndrome
- Insulin resistance
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19482